Total Funding
72
60
Total FundingPost-IPO Equity raised
Growth Score
-18 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
10774
Immuneering is a bioinformatics company that develops new medicines unlikely to be found by traditional drug discovery methods.
- Benjamin Zeskind: Co-Founder, President, Chief Executive Officer
- Carolina Garcia-Rizo: Chief Business OfficerPast Role: Just - Evotec Biologics, Chief Business Officer
About the Company
Immuneering is a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying its deep knowledge of translational bioinformatics to every stage of the drug development process. It has more than a decade of experience in translational
bioinformatics and generating insights into drug mechanisms of action and patient treatment responses.
